Lexicon Pharmaceuticals LXRX
NASDAQ LXRX
$1.86 +0.04 (+2.20%)
At close: Nov 10, 2026 · 4:00 PM EST

Lexicon Pharmaceuticals (LXRX) EV to EBIT (2015 - 2021)

Updated

Lexicon Pharmaceuticals' EV to EBIT was 13.47 in Q2 2021, compared with 0.24 a year earlier.

Analysis

Lexicon Pharmaceuticals (LXRX) EV to EBIT (2015 - 2021) Analysis & Trends

On a trailing twelve-month basis, Lexicon Pharmaceuticals' EV to EBIT was 3.45 through Jun 30, 2021; for FY2019, it was 1.22.

  • In earlier years, EV to EBIT was 585.71 in FY2015.
  • The Q2 2021 figure marks the highest quarterly EV to EBIT since Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Lexicon Pharmaceuticals 860.99 Mn 220.29 Mn 11.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 13.47
Jun 30, 2020 0.24
Mar 31, 2020 -0.42
Dec 31, 2019 1.22
Sep 30, 2019 0.13
Dec 31, 2015 585.71
API Access

Lexicon Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=LXRX&period=max&api_key=YOUR_API_KEY